1
|
Goodman CD, Garden AS, Wang H, Wang XA, Diao K, Lee A, Reddy J, Moreno AC, Spiotto MT, Fuller CD, Rosenthal DI, Ferrarotto R, Raza SM, Su SY, Hanna EY, DeMonte F, Phan J. Fractionated Stereotactic Radiotherapy in the Management of Dural Recurrence of Olfactory Neuroblastoma. Int J Radiat Oncol Biol Phys 2023; 117:e585-e586. [PMID: 37785774 DOI: 10.1016/j.ijrobp.2023.06.1929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Treatment protocols for dural recurrence among esthesioneuroblastoma patients have not been standardized. We assess the outcomes of fractionated stereotactic radiotherapy (FSR) for patients with olfactory neuroblastoma (ONB) dura-based recurrences. MATERIALS/METHODS We identified ONB patients with dura-based recurrences treated with FSR after prior radiotherapy who were enrolled between 2013 and 2022 in our prospective head and neck reirradiation and skull base registries. In-field tumor control (within 2 cm of prescribed radiotherapy volume) and out-of-field tumor control (non-contiguous or contralateral dura, nodal, or distant metastases) were analyzed. RESULTS Thirteen patients with 28 dural lesions were included in this analysis. All patients were initially treated with surgery to their primary paranasal sinus disease; 69% with a craniofacial approach followed by adjuvant radiotherapy to a median dose of 63 Gy (range 60-72.4 Gy) prescribed to the resected tumor bed. Patients re-presented with dural recurrence at median 58.3 months (range 35.0 - 163.0 months) from completion of their initial treatment. Two patients underwent dural resections. On presentation of recurrence, 4 patients had 1 lesion treated, with a median of 2 lesions treated (range 1-4 lesions). All dural based tumors were treated with FSR to a median dose of 27 Gy in 3 fractions delivered QOD. 68Ga-DOTATATE PET/CT was utilized for FSR treatment planning in 31% of cases. The median follow up from FSR was 23.3 months (range: 13.1 - 51.6 months). The 1-year overall survival and progression free survival was 75% and 38%, respectively. The 1- and 2-year in-field control rate was 85% and 75%, respectively. Among treated lesions, 25 of 28 (89%) responded or remained stable following FSR. Two patients (3 lesions) had evidence of in-field radiographic progression at 17 and 9 months, respectively. Five patients (38%) experienced progression in the contralateral or non-contiguous dura, and 5 patients (38%) developed distant metastases. The overall out-of-field progression rate was 58% at 1 year. There was no grade 3 or higher toxicity observed. Three patients (23%) developed asymptomatic changes on MRI consistent with brain necrosis, all of which occurred in a previously irradiated region. CONCLUSION In the largest single institution study of FSR reirradiation for ONB dural recurrence to date, high local control rates with minimal toxicity are attainable. However, subsequent out-of-field dural recurrences and/or distant metastases remain problematic.
Collapse
Affiliation(s)
- C D Goodman
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - A S Garden
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - H Wang
- Department of Radiation Physics, The University of Texas, MD Anderson Cancer Center, Houston, TX
| | - X A Wang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - K Diao
- University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - A Lee
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - J Reddy
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - A C Moreno
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - M T Spiotto
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - C D Fuller
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - D I Rosenthal
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - R Ferrarotto
- Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - S M Raza
- Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX
| | - S Y Su
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - E Y Hanna
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - F DeMonte
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - J Phan
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
2
|
Mu Y, Chen Y, Meng Y, Chen T, Fan X, Yuan J, Lin J, Pan J, Li G, Feng J, Diao K, Li Y, Yu S, Liu L. Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms. Front Oncol 2023; 13:1160383. [PMID: 37601650 PMCID: PMC10436202 DOI: 10.3389/fonc.2023.1160383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 07/03/2023] [Indexed: 08/22/2023] Open
Abstract
Background Next-generation sequencing (NGS) panels for mature B-cell neoplasms (MBNs) are widely applied clinically but have yet to be routinely used in a manner that is suitable for subtype differential diagnosis. This study retrospectively investigated newly diagnosed cases of MBNs from our laboratory to investigate mutation landscapes in Chinese patients with MBNs and to combine mutational information and machine learning (ML) into clinical applications for MBNs, especially for subtype classification. Methods Samples from the Catalogue Of Somatic Mutations In Cancer (COSMIC) database were collected for ML model construction and cases from our laboratory were used for ML model validation. Five repeats of 10-fold cross-validation Random Forest algorithm was used for ML model construction. Mutation detection was performed by NGS and tumor cell size was confirmed by cell morphology and/or flow cytometry in our laboratory. Results Totally 849 newly diagnosed MBN cases from our laboratory were retrospectively identified and included in mutational landscape analyses. Patterns of gene mutations in a variety of MBN subtypes were found, important to investigate tumorigenesis in MBNs. A long list of novel mutations was revealed, valuable to both functional studies and clinical applications. By combining gene mutation information revealed by NGS and ML, we established ML models that provide valuable information for MBN subtype classification. In total, 8895 cases of 8 subtypes of MBNs in the COSMIC database were collected and utilized for ML model construction, and the models were validated on the 849 MBN cases from our laboratory. A series of ML models was constructed in this study, and the most efficient model, with an accuracy of 0.87, was based on integration of NGS testing and tumor cell sizes. Conclusions The ML models were of great significance in the differential diagnosis of all cases and different MBN subtypes. Additionally, using NGS results to assist in subtype classification of MBNs by method of ML has positive clinical potential.
Collapse
Affiliation(s)
- Yafei Mu
- Department of Hematology, The Third Affiliated Hospital of Sun Yat‐sen University and Sun Yat‐sen Institute of Hematology, Guangzhou, China
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Yuxin Chen
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
- Guangzhou KingMed Diagnostics Group Co., Ltd., Guangzhou, China
| | - Yuhuan Meng
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
- Guangzhou KingMed Diagnostics Group Co., Ltd., Guangzhou, China
| | - Tao Chen
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Xijie Fan
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Jiecheng Yuan
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Junwei Lin
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Jianhua Pan
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
- Guangzhou KingMed Diagnostics Group Co., Ltd., Guangzhou, China
| | - Guibin Li
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
| | - Jinghua Feng
- Guangzhou KingMed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
| | - Kaiyuan Diao
- Guangzhou KingMed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
| | - Yinghua Li
- Guangzhou KingMed Diagnostics Group Co., Ltd., Guangzhou, China
| | - Shihui Yu
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China
- Guangzhou KingMed Transformative Medicine Institute Co., Ltd., Guangzhou, China
- Guangzhou KingMed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
- Guangzhou KingMed Diagnostics Group Co., Ltd., Guangzhou, China
| | - Lingling Liu
- Department of Hematology, The Third Affiliated Hospital of Sun Yat‐sen University and Sun Yat‐sen Institute of Hematology, Guangzhou, China
| |
Collapse
|
3
|
Diao K, Lei X, Smith G, Jagsi R, Smith B, Sher D. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors after Primary Radiotherapy or Surgery. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
4
|
Diao K, Netherton T, Moreno A, Reddy J, Wang H, Phan J. Dosimetric Analysis of Lingual Artery Bleeding Events after Stereotactic Ablative Radiotherapy Reirradiation of Head and Neck Cancers. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
5
|
Andring L, Diao K, Sun S, Patel M, Schlembach P, Arzu I, Joyner M, Shaitelman S, Hoffman K, Stauder M, Smith B, Woodward W. Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
Chen H, Wu L, Diao K, Sheng Y, Chen X, Song Y, Jin Q, Yang P, Song J. Identification of "antigen-specific" neutrophils in atherosclerosis patients that compromise vascular endothelial barrier function. Am J Transl Res 2020; 12:6827-6840. [PMID: 33194075 PMCID: PMC7653617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2020] [Accepted: 10/03/2020] [Indexed: 06/11/2023]
Abstract
The vascular endothelial barrier dysfunction is associated with the pathogenesis of many cardiovascular diseases, such as atherosclerosis (AS). This study aims to identify specific antigen (Ag, in short)-specific polymorphonuclear neutrophils (PMN) in AS patients and to investigate the role of "Ag-specific" PMN activation in causing vascular endothelial barrier dysfunction. In this study, PMNs were isolated from blood samples collected from patients with AS and analyzed with immunological approaches. Human umbilical vein endothelial cells (HUVEC) monolayers were used as a vascular endothelial barrier model. The results showed that "Ag-specific" PMNs were identified in the blood of 50 AS patients. This subset of PMN was featured as the FcγRI and specific IgG (sIgG) complexes on the cell surface; exposure to specific Ags triggered the "Ag-specific" PMNs to release proinflammatory cytokines. PMN-derived cytokine levels in the serum were positively correlated with the serum levels of sIgG in AS patients. Exposure of naive PMNs to sIgG formed FcγRI and sIgG complexes on the surface; this conferred PMNs the property to be recognized and activated by specific Ag. Stimulation of "Ag-specific" PMN activated the mitogen-activated protein kinase and the activities of nuclear factor activated T cells and promoted the gene transcription of tumor necrosis factor-α. Coculture of "Ag-specific" PMNs and HUVEC monolayers in the presence of specific Ag resulted in the HUVEC monolayer barrier dysfunction. In conclusion, "Ag-specific" PMNs were identified in AS patients. Activation of the PMNs compromised vascular endothelial barrier function. Therefore, to regulate the "Ag-specific" PMN's activities may have translational potential in the treatment of AS.
Collapse
Affiliation(s)
- Haisheng Chen
- Department of Cardiovascular Surgery, Guangzhou First People’s Hospital, School of Medicine, South China University of TechnologyGuangzhou, Guangdong, China
| | - Liying Wu
- Department of Cardiovascular Surgery, Guangzhou First People’s Hospital, School of Medicine, South China University of TechnologyGuangzhou, Guangdong, China
| | - Kaiyuan Diao
- Research Center of Allergy & Immunology, Shenzhen University School of MedicineShenzhen, China
| | - Yixuan Sheng
- Department of Cardiovascular Surgery, Guangzhou First People’s Hospital, School of Medicine, South China University of TechnologyGuangzhou, Guangdong, China
| | - Xiao Chen
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College167A Beilishi Road, Beijing, China
| | - Yannan Song
- Research Center of Allergy & Immunology, Shenzhen University School of MedicineShenzhen, China
| | - Qiaoruo Jin
- Research Center of Allergy & Immunology, Shenzhen University School of MedicineShenzhen, China
- Guangdong Provincial Key Laboratory of Regional Immunity and DiseasesShenzhen, China
| | - Pingchang Yang
- Research Center of Allergy & Immunology, Shenzhen University School of MedicineShenzhen, China
- Guangdong Provincial Key Laboratory of Regional Immunity and DiseasesShenzhen, China
| | - Jiangping Song
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College167A Beilishi Road, Beijing, China
| |
Collapse
|
7
|
Diao K, Swanick C, Lei X, Xu Y, Shen Y, Smith G, Giordano S, DeSnyder S, Hunt K, Teshome M, Jagsi R, Shaitelman S, Peterson S, Smith B. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes after Breast Conserving Therapy in Older Breast Cancer Survivors. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Bitterman D, Rawal B, Atkins K, Chaunzwa T, Diao K, Catalano P, Baldini E, Chen A, Kozono D, Mak R. Predictors of Radiation Esophagitis in Locally Advanced Non-Small Cell Lung Cancer with Modern Radiation Therapy Planning. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
9
|
Diao K, Bian S, Ji L, Groshen S, Routman D, Yu C, Wagle N, Zada G, Chang E. Acute and Late Toxicities in the Setting of Combination Stereotactic Radiosurgery and Ipilimumab for Patients With Melanoma Brain Metastases. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Diao K, Chen Y, Catalano P, Lee S, Milani N, Killoran J, Baldini E, Chen A, Kozono D, Mak R. Radiation Toxicity in Patients with Collagen Vascular Disease and Intrathoracic Malignancy Treated with Modern Radiotherapy. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Kairy S, Rometsch P, Diao K, Nie J, Davies C, Birbilis N. Exploring the electrochemistry of 6xxx series aluminium alloys as a function of Si to Mg ratio, Cu content, ageing conditions and microstructure. Electrochim Acta 2016. [DOI: 10.1016/j.electacta.2015.12.098] [Citation(s) in RCA: 58] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Diao K, Farmani R, Fu G, Astaraie-Imani M, Ward S, Butler D. Clustering analysis of water distribution systems: identifying critical components and community impacts. Water Sci Technol 2014; 70:1764-1773. [PMID: 25500465 DOI: 10.2166/wst.2014.268] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Large water distribution systems (WDSs) are networks with both topological and behavioural complexity. Thereby, it is usually difficult to identify the key features of the properties of the system, and subsequently all the critical components within the system for a given purpose of design or control. One way is, however, to more explicitly visualize the network structure and interactions between components by dividing a WDS into a number of clusters (subsystems). Accordingly, this paper introduces a clustering strategy that decomposes WDSs into clusters with stronger internal connections than external connections. The detected cluster layout is very similar to the community structure of the served urban area. As WDSs may expand along with urban development in a community-by-community manner, the correspondingly formed distribution clusters may reveal some crucial configurations of WDSs. For verification, the method is applied to identify all the critical links during firefighting for the vulnerability analysis of a real-world WDS. Moreover, both the most critical pipes and clusters are addressed, given the consequences of pipe failure. Compared with the enumeration method, the method used in this study identifies the same group of the most critical components, and provides similar criticality prioritizations of them in a more computationally efficient time.
Collapse
Affiliation(s)
- K Diao
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| | - R Farmani
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| | - G Fu
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| | - M Astaraie-Imani
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| | - S Ward
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| | - D Butler
- Centre for Water Systems, University of Exeter, Exeter EX6 7HS, UK E-mail:
| |
Collapse
|
13
|
Diao K, Holmes J, Hou Y, Hendrix L, Hoffman L, Mintz J, Cameron T, Xu Z, Wang A, Chen R. Comparative Patient-reported Quality of Life (QOL) During Radiation Therapy (RT) in Patients Receiving Definitive RT Versus Postprostatectomy RT for Prostate Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Diao K, Yirmibesoglu E, Hoffman L, Hendrix L, Holmes J, Hou Y, Xu Z, Wang Z, Chen R. Patient-Reported Quality of Life (QOL) during Image-Guided Intensity Modulated Radiation Therapy (IGRT) for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
|
16
|
Yu H, Li H, Xu S, Ma L, Diao K. [Determianation of trace copper, iron and lead in purified AgNO3 with liquid membrane enrichment]. Guang Pu Xue Yu Guang Pu Fen Xi 1997; 17:76-79. [PMID: 15810252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
In this paper a new method of preconcentrating microimpurity Cu, Fe and Pb in high pure AgNO3 using emulsion liquid membrane technique was developed for FAAS determination. The enrichment multiple was 25, recoveries were over 95%. Matrix silver does not interfere enrichment and determination.
Collapse
Affiliation(s)
- H Yu
- Department of Chemistry, Changchun Normal College, 130032 Changchun
| | | | | | | | | |
Collapse
|